Clinical Trial

DIALYSIS-TIR Study

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study will look at control of blood sugar levels in persons with type 2 diabetes mellitus currently on chronic dialysis. Researchers will compare blood sugar levels in people taking semaglutide to people taking "dummy" medicine. The treatment participants get will be decided randomly. Participants will need to inject the study medication once a week. The study will last for 1 year and a month. Participants will be asked to wear a sensor that measures blood sugar levels for a period of 10 days at five different time points during the study.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-09-11; most recent amendment 2026-01-09.
Status change: Recruiting → Active, Not Recruiting 2026-01-09
Status change: Not Yet Recruiting → Recruiting 2024-01-09
Trial Details
NCT Number NCT06042153
Lead Sponsor University of Texas Southwestern Medical Center
Collaborators: University of North Carolina, Chapel Hill
Conditions Type 2 Diabetes, End Stage Renal Disease on Dialysis
Enrollment 43 participants
Start Date 2023-12-05
Primary Completion 2027-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-01-13